Literature DB >> 8456944

Co-localization of von Willebrand factor and type VI collagen in human vascular subendothelium.

J H Rand1, X X Wu, B J Potter, R R Uson, R E Gordon.   

Abstract

The binding of von Willebrand factor (vWF) to subendothelium constitutes an important initial step in the process of platelet adhesion to exposed subendothelium following blood vessel injury. We previously demonstrated that vWF is present in human vascular subendothelium and recently found that a 150 kd vWF-binding protein, which we extracted from subendothelium, is type VI collagen. Although we have established that vWF and type VI collagen bind in vitro, it is not known whether these two proteins are associated in the vascular subendothelium in situ. We, therefore, 1) investigated the morphological effects of our biochemical extraction procedure on human umbilical veins by scanning and transmission electron microscopy, 2) analyzed the subendothelial extract by immunofluorescence for the presence of vWF and collagens and by electron microscopy for morphological characteristics, and 3) localized vWF and type VI collagen in subendothelium by immunofluorescence and by single- and double-label immunoelectron microscopic studies with protein A-conjugated gold particles. We found that the surface exposed following de-endothelialization is composed of microfibrils and contains very little fibrillar collagen. The subendothelium is stripped after sodium dodecyl sulfate-urea extraction, and the extract itself contains immunoreactive vWF and type VI collagen but no immunoreactive type I or III fibrillar collagens. Immunofluorescence and immunoelectron microscopic studies showed that vWF and type VI collagen are both present in subendothelium, where both co-localized to microfibrils. In conclusion, vWF that binds to type VI collagen in vitro, also co-localizes with type VI collagen in subendothelium, where both are associated with microfibrils. Type VI collagen, therefore appears to serve as a biologically significant binding site for vWF in vivo and may thereby play a role in mediating platelet adhesion to exposed subendothelium following vascular injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8456944      PMCID: PMC1886814     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Factor VIII/von Willebrand factor in subendothelium mediates platelet adhesion.

Authors:  V T Turitto; H J Weiss; T S Zimmerman; I I Sussman
Journal:  Blood       Date:  1985-04       Impact factor: 22.113

2.  Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor.

Authors:  F Fauvel; M E Grant; Y J Legrand; H Souchon; G Tobelem; D S Jackson; J P Caen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

3.  Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens.

Authors:  S A Santoro
Journal:  Thromb Res       Date:  1981-03-15       Impact factor: 3.944

4.  Subendothelial deposition of von Willebrand's factor requires the presence of endothelial cells.

Authors:  I I Sussman; J H Rand
Journal:  J Lab Clin Med       Date:  1982-10

5.  The collagenous components of the subendothelium. Correlation of structure and function.

Authors:  J A Madri; B Dreyer; F A Pitlick; H Furthmayr
Journal:  Lab Invest       Date:  1980-10       Impact factor: 5.662

6.  The preparation of protein A-gold complexes with 3 nm and 15nm gold particles and their use in labelling multiple antigens on ultra-thin sections.

Authors:  J Roth
Journal:  Histochem J       Date:  1982-09

7.  Distribution of type I, III, IV and V collagen in normal and atherosclerotic human arterial wall: immunomorphological characteristics.

Authors:  B V Shekhonin; S P Domogatsky; V R Muzykantov; G L Idelson; V S Rukosuev
Journal:  Coll Relat Res       Date:  1985-09

8.  Platelet interaction with rabbit subendothelium in von Willebrand's disease: altered thrombus formation distinct from defective platelet adhesion.

Authors:  V T Turitto; H J Weiss; H R Baumgartner
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

9.  Glanzmann thrombasthenia: deficient binding of von Willebrand factor to thrombin-stimulated platelets.

Authors:  Z M Ruggeri; R Bader; L de Marco
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Von Willebrand factor in the vessel wall mediates platelet adherence.

Authors:  H V Stel; K S Sakariassen; P G de Groot; J A van Mourik; J J Sixma
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

View more
  5 in total

1.  Critical von Willebrand factor A1 domain residues influence type VI collagen binding.

Authors:  V H Flood; J C Gill; P A Christopherson; D B Bellissimo; K D Friedman; S L Haberichter; S R Lentz; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

2.  Morphological relationships of von Willebrand factor, type VI collagen, and fibrillin in human vascular subendothelium.

Authors:  X X Wu; R E Gordon; R W Glanville; H J Kuo; R R Uson; J H Rand
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

3.  von Willebrand factor binds to native collagen VI primarily via its A1 domain.

Authors:  M F Hoylaerts; H Yamamoto; K Nuyts; I Vreys; H Deckmyn; J Vermylen
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Von Willebrand Factor permeates small vessels in CADASIL and inhibits smooth muscle gene expression.

Authors:  Xiaojie Zhang; He Meng; Mila Blaivas; Elisabeth J Rushing; Brian E Moore; Jessica Schwartz; M Beatriz S Lopes; Bradford B Worrall; Michael M Wang
Journal:  Transl Stroke Res       Date:  2011-10-20       Impact factor: 6.829

5.  Stable engineered vascular networks from human induced pluripotent stem cell-derived endothelial cells cultured in synthetic hydrogels.

Authors:  Matthew R Zanotelli; Hamisha Ardalani; Jue Zhang; Zhonggang Hou; Eric H Nguyen; Scott Swanson; Bao Kim Nguyen; Jennifer Bolin; Angela Elwell; Lauren L Bischel; Angela W Xie; Ron Stewart; David J Beebe; James A Thomson; Michael P Schwartz; William L Murphy
Journal:  Acta Biomater       Date:  2016-03-02       Impact factor: 8.947

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.